Rural Health
News by Topic: COVID-19
FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability
Federal Register
Dec 8, 2025 - The Food and Drug Administration (FDA) has revoked an Emergency Use Authorization issued to Genentech, Inc. (Genentech) for Actemra (tocilizumab). The revocation is effective August 8, 2025.
Source: Federal Register